The U.S. Securities and Exchange Commission (SEC) on Wednesday added four Chinese firms to the potential delisting list over the next three years as Beijing continues to deny the U.S. review of their auditors’ work.
The SEC added Baidu Inc., Futu Holdings Limited, Nocera Inc., iQIYI Inc., and CASI Pharmaceuticals Inc. to its provisional list for possible delisting.
These additions bring the total number of firms identified to 11.
Under the Holding Foreign Companies Accountable Act (HFCAA), Washington has permission to access the books of listed companies on the U.S. stock exchanges, including Chinese firms. However, Beijing prohibits foreign review of domestic companies’ accounting papers.
On March 8, SEC listed the first five Chinese firms on a provisional list that could lead to delisting from U.S. exchanges.
In its response, China’s securities regulator said on March 11 that they were negotiating with U.S. officials and were making “positive progress.”
In an interview with Bloomberg on Tuesday, SEC Chair Gary Gensler mentioned ongoing negotiations. He said,
Last December, SEC stated it had 273 U.S.-listed Chinese companies at risk of being delisted without revealing their names.
This event was part of the ongoing audit standoff between China and the U.S. The Chinese government has barred domestic corporations and their Chinese auditors from complying with such requests from foreign authorities.